Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

134.2800 USD 1.5400 1.13%

As of 20:04:01 ET on 04/24/2015.

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 135.0000 High - Low: 135.7300 - 134.2400 Primary Exchange: NYSE Arca
Volume: 53,005 52-Week Range: 82.7300 - 140.7200 Beta vs MVBBHTR: 1.0007

ETF Chart for BBH

No chart data available.
  • BBH:US 134.2800
  • 1D
  • 1M
  • 1Y
135.8200
Interactive BBH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2015-04-24) 134.2339
Assets (M) (on 2015-04-24) 818.3577
Shares out (M) 6.10
Market Cap (M) 818.64
% Premium 0.03
Average 52-Week % Premium -0.0056
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-12-23) 0.0030
Dividend Yield (ttm) -%

Performance for BBH

1-Month -0.22% 1-Year +53.64%
3-Month +8.15% 3-Year +44.34%
Year To Date +16.38% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 04/23/2015
Name Position Value % of Total
Gilead Sciences Inc 1,109,208 116,694,228 14.083%
Amgen Inc 596,545 100,917,518 12.179%
Celgene Corp 737,005 85,558,910 10.326%
Biogen Inc 162,591 69,959,655 8.443%
Regeneron Pharmaceuticals Inc 92,617 44,463,569 5.366%
Vertex Pharmaceuticals Inc 288,554 39,191,404 4.730%
BioMarin Pharmaceutical Inc 309,203 38,016,509 4.588%
Alexion Pharmaceuticals Inc 197,909 36,530,043 4.409%
Illumina Inc 186,024 35,828,222 4.324%
Incyte Corp 319,310 34,437,584 4.156%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil